KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Non-Current Deferred Tax Liability: 2010-2015

Historic Non-Current Deferred Tax Liability for Biomarin Pharmaceutical (BMRN) over the last 4 years, with Dec 2015 value amounting to $143.5 million.

  • Biomarin Pharmaceutical's Non-Current Deferred Tax Liability fell 25.71% to $143.5 million in Q1 2016 from the same period last year, while for Mar 2016 it was $143.5 million, marking a year-over-year decrease of 25.71%. This contributed to the annual value of $143.5 million for FY2015, which is N/A change from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Non-Current Deferred Tax Liability stood at $143.5 million for FY2015, which was up 331.06% from $33.3 million recorded in FY2012.
  • In the past 5 years, Biomarin Pharmaceutical's Non-Current Deferred Tax Liability ranged from a high of $143.5 million in FY2015 and a low of $33.3 million during FY2012.
  • Its 1-year average for Non-Current Deferred Tax Liability is $143.5 million, with a median of $143.5 million in 2015.
  • In the last 5 years, Biomarin Pharmaceutical's Non-Current Deferred Tax Liability climbed by 1.75% in 2011 and then declined by 10.39% in 2012.
  • Yearly analysis of 3 years shows Biomarin Pharmaceutical's Non-Current Deferred Tax Liability stood at $37.2 million in 2011, then dropped by 10.39% to $33.3 million in 2012, then reached $143.5 million in 2015.